Xpertin 50 Powder for Oral Suspension contains Cefpodoxime Proxetil equivalent to 50 mg per 5 ml, a third-generation cephalosporin antibiotic with broad-spectrum bactericidal activity. It is indicated for the treatment of various bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and otitis media caused by susceptible organisms. Cefpodoxime Proxetil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The powder formulation is reconstituted with water to produce a palatable oral suspension, facilitating administration in pediatric and adult patients who have difficulty swallowing tablets. Xpertin 50 demonstrates efficacy against both Gram-positive and Gram-negative pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli. Dosage and duration of therapy should be individualized based on the severity of infection, patient age, renal function, and clinical response. Common adverse effects include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain, while hypersensitivity reactions may occur in patients with beta-lactam allergies. Caution is advised in patients with a history of penicillin allergy. Xpertin 50 should be used under medical supervision, ensuring appropriate microbiological diagnosis and monitoring for therapeutic efficacy and adverse events.